InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: None

Tuesday, 05/03/2016 1:40:02 PM

Tuesday, May 03, 2016 1:40:02 PM

Post# of 232115
Some investors seem to be concerned about the company progressing with GvHD and not focusing solely on HIV at the moment. As explained by management, the cost to proceed with GvHD along with HIV is only about $4 million as it's going to be using PRO-140 and not a new therapy. If CYDY were to receive a buyout offer in the near future, having GvHD in the portfolio would certainly bump up the premium by some amount. If they had to spend $50 - 100M on GvHD then maybe I would have been concerned. But not with $4-5M. I am very happy with how they are progressing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News